Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Aug
8
2014
 FDA Announces Intent to Issue Draft Guidance Documents Describing Regulatory Framework for Laboratory Developed Tests Covington & Burling LLP
Aug
8
2014
 Medical Devices: Parallel Claims Against Device Manufacturers post-Riegel? Sills Cummis & Gross P.C.
Aug
8
2014
 NLRB’s Sobering Decision Permits Union Representation Before Employee Drug Test Jackson Lewis P.C.
Aug
7
2014
 FDA Releases Final Guidance on Expedited Center for Devices and Radiological Health (CDRH) Appeals Barnes & Thornburg LLP
Aug
7
2014
 3D-Matrix, Ltd. v. Menicon Co., Ltd., Denying Institution of Inter Partes Review IPR2014-00398 Faegre Drinker
Aug
7
2014
 Fed. Cir.: Antitrust Issues Can Arise From Hatch-Waxman Litigation
Aug
6
2014
 Anticipated Framework for Regulatory Oversight of Laboratory Developed Tests McDermott Will & Emery
Aug
6
2014
 Medical Device Update: FDA Issues Final Guidance on 510(k) Determinations, Use of “Split” Predicates Strongly Discouraged Morgan, Lewis & Bockius LLP
Aug
6
2014
 D.C. Circuit Rejects Toxic Tort Claims Based on Aerial Spraying of Herbicide Beveridge & Diamond PC
Aug
5
2014
 Summary Of FDA Advertising and Promotion Enforcement Activities Covington & Burling LLP
Aug
5
2014
 The Electronic Wallet System: How Nigeria Is Dialing Into Its Agricultural Sector Covington & Burling LLP
Aug
4
2014
 Ignorance is Bliss – for Teva re: Structural Obviousness in Patent Cases
Aug
4
2014
 Commission Updates EU Medical Devices Borderline Manual Covington & Burling LLP
Aug
4
2014
 FDA Issues Updated Draft Guidance on Reporting Drug Samples Morgan, Lewis & Bockius LLP
Aug
3
2014
 EcoWater Systems LLC v. Culligan International Co., Inter Partes Review Still Difficult for Patent Owners McDermott Will & Emery
Aug
3
2014
 Dissent at the Patent Trial and Appeal Board (PTAB) Leads to … Unpatentability McDermott Will & Emery
Aug
2
2014
 Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc., Denying Institution IPR2014-00361 Faegre Drinker
Aug
1
2014
 What’s New Under the Food Safety Modernization Act? Beveridge & Diamond PC
Jul
31
2014
 FDA Releases Details of New Framework for Laboratory Developed Tests Regulation Morgan, Lewis & Bockius LLP
Jul
31
2014
 FDA Finalizes Appeals Guidance on Section 517A of the Food, Drug, and Cosmetic Act Covington & Burling LLP
Jul
31
2014
 USPTO TRIPs Over Myriad-Mayo Guidance - Trade-related Aspects of Intellectual Property Rights
Jul
31
2014
 Contractual Duty to Deal Does Not Equal Antitrust Duty to Deal McDermott Will & Emery
Jul
31
2014
 Energy Technology Connections - July 2014 Mintz
Jul
31
2014
 Intelligent Bio-Systems, Inc. v. Illumina Cambridge Limited, Final Written Decision IPR2013-00128 Faegre Drinker
Jul
31
2014
 A Compound Is Obvious Where Only Minor Changes to a Prior Art “Lead Compound” Are Required to Make the Claimed Compound McDermott Will & Emery
Jul
30
2014
 Obviousness Only Requires Reasonable Expectation of Success of One Compound Encompassed by Broad Genus Claims McDermott Will & Emery
Jul
30
2014
 European Commission Fines Servier and Five Generic Companies for Preventing Entry of Generic Versions of Blood Pressure Control Drug Covington & Burling LLP
Jul
30
2014
 The Race is on! Anxiously Waiting for the First U.S. Biosimilar to Cross the Finish Line Michael Best & Friedrich LLP
Displaying 11089 - 11116 of 12449
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters